Grateful to Dr. Dinara Ryspayeva for presenting the manuscript on PPAR-delta as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-delta as a prognostic biomarker and its association with immune infiltrates in breast cancer at #eldeirylab meeting at #LegorretaCancerCenter @BrownMedicine @Dina_rys
image image image
Dr. El-Deiry hosts Dr. Sherise Rogers for the Legorreta Cancer Center's Director's Podcast on 12-10-2025 youtu.be/2JiAhtkBgGI via @YouTube @SheRiseRogersMD #LegorretaCancerCenter
Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology https://medicalxpress.com/news/2025-12-reversing-treatment-resistance-prostate-cancer.html
Study Reveals Surprisingly Obvious Reason Why Exercise Reduces Cancer Risk
ScienceAlert
Study Reveals Surprisingly Obvious Reason Why Exercise Reduces Cancer Risk
There's a lot of evidence that more exercise helps reduce cancer risk – but why are the two connected? According to a new mouse study, it ma...
Outstanding meeting of international @WIN_Consortium Genitourinary (GU) Cancer Committee with excellent discussions of plans to develop precision oncology N-of-1 clinical studies, unique collaboration opportunities with pharma & partners including cancer centers, advocacy groups, @AmericanCancer, @SWOG among others. We heard presentation by Ethan Stancliff of Panome Bio about opportunities with proteomics and metabolomics in precision oncology. @WilliamOhMD @bcarneiro7 @drmnstein @Dr_R_Kurzrock
image image image image
NIH chief defends new funding model
NIH chief defends new funding model
Dr. Jay Bhattacharya said he wants other states to compete for research funding with Massachusetts on β€˜level playing fields’
Cancer detection firm Freenome to go public via $330 million SPAC deal
STAT
Cancer detection firm Freenome to go public via $330 million SPAC deal
Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through blood-based tests, plans t...
American Cancer Society Endorses Pap Smear Alternative The recommendation comes after the first at-home test, a self-swab, received federal approval earlier this year.
American Cancer Society Endorses Pap Smear Alternative
The recommendation comes after the first at-home test, a self-swab, received federal approval earlier this year.
A Rare Cancer Is Surging in Young People, And Experts Are Puzzled
ScienceAlert
A Rare Cancer Is Surging in Young People, And Experts Are Puzzled
A very rare type of cancer is on a sharp upward trajectory in younger generations, and no one knows why.
The Transgender Cancer Patient and What She Heard on Tape Jennifer Capasso had endured multiple tumors. She wondered what might be said during her next cancer surgery. So, she hit record on her phone.
The Transgender Cancer Patient and What She Heard on Tape
Jennifer Capasso had endured multiple tumors. She wondered what might be said during her next cancer surgery. So, she hit record on her phone.